The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
NCT02337556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2018-01-26
Summary
To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.
Conditions
- Critically Ill Mechanically Ventilated Subjects
Interventions
- OTHER
-
Peptamen Bariatric
Commercially available enteral diet
- OTHER
-
Replete
Commercially available enteral diet
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2016-10-31
- Completion
- 2016-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
NCT01557296 ·Status: COMPLETED ·Phase: PHASE2
-
Determinants of Diabetes Remission After Gastric Bypass Surgery
NCT02287285 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
NCT01825148 ·Status: COMPLETED
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery
NCT02550145 ·Status: TERMINATED ·Phase: PHASE1
-
Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients
NCT01727583 ·Status: COMPLETED ·Phase: NA
-
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01843855 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
NCT00747968 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cardiovascular Effects of GLP-1 Receptor Activation
NCT03101930 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Detemir in Obesity Management
NCT01239550 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
Incretin Regulation of Insulin Secretion in Monogenic Diabetes
NCT01795144 ·Status: COMPLETED ·Phase: PHASE1
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
NCT00005889 ·Status: UNKNOWN ·Phase: NA
-
The Glucagonotropic Effect of Amino Acids in Humans
NCT05954923 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
NCT01803451 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
NCT04466566 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
NCT06679270 ·Status: RECRUITING ·Phase: PHASE3
-
Vagal Nerve Stimulation and Glucose Metabolism
NCT01117311 ·Status: COMPLETED ·Phase: NA
-
Regulation of Insulin Secretion by the GLP-1 Receptor
NCT02844907 ·Status: TERMINATED ·Phase: PHASE4
-
Balance System Study in Type 2 Diabetic Patients
NCT00872846 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes
NCT01771250 ·Status: COMPLETED ·Phase: PHASE1